ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain

Part of paid clinical trials in Sun City, Arizona.

Sponsor
Brixton Biosciences, Inc.
Study ID
NCT07568015
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Greater Trochanteric Pain Syndrome
  • Greater Trochanteric Pain Syndrome of Both Lower Limbs
  • Lateral Hip Pain

Eligibility Criteria

Sex
ALL
Age
22 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Triamcinolone acetate — DRUG
    A single dose of Triamcinolone 40mg injected directly into the hip joint.
  • ReneuRx — DEVICE
    ReneuRx will be injected around the trochanteric branches of the femoral nerve.

Study Details

The goal of this clinical trial is to evaluate the safety and analgesic performance of the ReneuRx™ device in subjects with moderate to severe chronic lateral hip pain compared to subjects receiving treatment with corticosteroid injection in adults aged 22-80 years. Participants will attend study visits and complete quality of life questionnaires. Participants will be followed for approximately 6-12 months after the study procedure.

Key Dates

Start date
Jul 1, 2026
Status verified
Jun 2026
Primary completion
Nov 1, 2027
Completion
Nov 1, 2029

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Triamcinolone acetate
    Corticosteroid injection
  • Experimental: ReneuRx

Primary Outcome Measure

Primary Effectiveness [ Time Frame: 3-months post treatment ]

Central Contacts

Locations (11)

FacilityCityStateZIPSite coordinators
Healthcare Outcomes Performance CompanySun CityArizona85023
Alison Klika
[email protected]
440-343-2001
John Kearney (PRINCIPAL_INVESTIGATOR)
Emory Orthopedics and Spine CenterJohns CreekGeorgia30097
Lavanya Veda
[email protected]
404-778-6608
Casey Wagner (PRINCIPAL_INVESTIGATOR)
Ochsner Health CenterNew OrleansLouisiana70121
Latrell Mackey
[email protected]
Maged Guirguis (PRINCIPAL_INVESTIGATOR)
Skylight Health ResearchBurlingtonMassachusetts01803
Alisha Garibaldi
[email protected]
781-328-6185
Tom McAlindon (PRINCIPAL_INVESTIGATOR)
Mass General BrighamChestnut HillMassachusetts02467
Kahtryn Satko
[email protected]
617-732-9816
Robert Yong (PRINCIPAL_INVESTIGATOR)
Virtua HealthSewellNew Jersey08080
Judith Conner
[email protected]
856-325-3264
Sean McMillan (PRINCIPAL_INVESTIGATOR)
The Orthopaedic CenterTulsaOklahoma74137
Jessica Good
[email protected]
918-991-3602
Yogesh Mittal (PRINCIPAL_INVESTIGATOR)
Rothman OrthopaedicsKing of PrussiaPennsylvania19406
Thema Nicholson
[email protected]
267-339-3615
Steve Stache (PRINCIPAL_INVESTIGATOR)
Pain Diagnostics & Interventional CareSewickleyPennsylvania15143
Alyssa Abrams
[email protected]
412-221-7640
David Provenzano (PRINCIPAL_INVESTIGATOR)
University of Texas Southwestern Medical CenterDallasTexas75390
Jonathan Thompson
[email protected]
214-645-2260
Kelechi Okoroha (PRINCIPAL_INVESTIGATOR)
All-American Orthopedic & SportsHoustonTexas77058
Austin Mercier
[email protected]
409-904-7991
Matthew Higgs (PRINCIPAL_INVESTIGATOR)

Find similar trials in Sun City, AZ

By research site
Healthcare Outcomes Performance Company· Sun City, AZEmory Orthopedics and Spine Center· Johns Creek, GAOchsner Health Center· New Orleans, LASkylight Health Research· Burlington, MAMass General Brigham· Chestnut Hill, MAVirtua Health· Sewell, NJ

Related Studies